sodium thiosulfate has been researched along with Head and Neck Neoplasms in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (10.53) | 18.7374 |
1990's | 5 (26.32) | 18.2507 |
2000's | 9 (47.37) | 29.6817 |
2010's | 3 (15.79) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bairati, I; Bussières, R; Côté, M; Guitton, MJ; Leclerc, M; Meyer, F; Philippon, D; Rolland, V | 1 |
Endo, K; Hatano, M; Ishikawa, E; Ito, M; Kondo, S; Murono, S; Nakanishi, Y; Sugimoto, H; Tsuji, A; Wakisaka, N; Yoshizaki, T | 1 |
Fujii, M; Homma, A; Matsuura, K; Onimaru, R; Robbins, KT | 1 |
Blakley, BW; Campbell, KC; Cohen, JI; Dickey, DT; Doolittle, ND; Muldoon, LL; Neuwelt, EA | 1 |
Yokoyama, J | 2 |
Doweck, I; Kumar, P; Robbins, KT; Samant, S; Vieira, F | 1 |
Bitter, K; Böttcher, HD; Kovács, AF; Mose, S | 1 |
Begleiter, A; Blakley, BB; Leith, MK; Viallet, NR | 1 |
Balm, AJ; Dreschler, WA; Hart, AA; Lansdaal, PE; Rasch, CR; Schornagel, JH; Simis, YJ; Zuur, CL | 2 |
Furukawa, M; Kondo, S; Matsui, O; Murono, S; Sanada, J; Shimizu, Y; Takanaka, T; Terayama, N; Wakisaka, N; Yoshizaki, T | 1 |
Esaki, S; Hayata, S; Hirano, M; Hitoshi, T; Kiyokawa, K; Mihashi, S | 1 |
Hanchett, C; Howell, SB; Kerber, C; Los, G; Robbins, KT; Seagren, S; Shea, M; Storniolo, AM; Vicario, D | 1 |
Howell, SB; Kerber, C; Los, G; Orloff, L; Pellitteri, P; Robbins, KT; Seagren, S; Vicario, D; Weisman, R | 1 |
Leake, F; Madasu, R; Robbins, KT; Ruckenstein, MJ; Steere, E | 1 |
Denys, D; Kumar, P; Newman, LA; Robbins, KT; Wong, FS | 1 |
Madasu, R; Martin, A; Murry, T; Robbins, KT | 1 |
Ikeda, K | 1 |
2 review(s) available for sodium thiosulfate and Head and Neck Neoplasms
Article | Year |
---|---|
Intra-arterial chemoradiotherapy for head and neck cancer.
Topics: Chemoradiotherapy; Cisplatin; Clinical Trials as Topic; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Japan; Middle Aged; Protective Agents; Thiosulfates | 2016 |
[Present role and future prospect of superselective intra-arterial infusion chemotherapy for head and neck cancer].
Topics: Adult; Aged; Antidotes; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Paclitaxel; Prospective Studies; Taxoids; Thiosulfates | 2002 |
5 trial(s) available for sodium thiosulfate and Head and Neck Neoplasms
Article | Year |
---|---|
A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
Topics: Aged; Antineoplastic Agents; Antioxidants; Carcinoma, Squamous Cell; Cisplatin; Female; Head and Neck Neoplasms; Hearing Loss; Humans; Injection, Intratympanic; Male; Middle Aged; Thiosulfates; Treatment Outcome | 2019 |
Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Head; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Male; Middle Aged; Neck; Neck Dissection; Neoadjuvant Therapy; Neoplasm Staging; Postoperative Care; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Taxoids; Thiosulfates; Time Factors; Treatment Outcome | 2005 |
Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Topics: Antineoplastic Agents; Auditory Threshold; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Ear, Inner; Female; Head and Neck Neoplasms; Hearing Loss; Hearing Loss, Sensorineural; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Radiotherapy Dosage; Thiosulfates | 2007 |
Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer.
Topics: Adult; Aged; Analysis of Variance; Anemia; Cisplatin; Drug Administration Schedule; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neutropenia; Pilot Projects; Remission Induction; Survival Rate; Thiosulfates | 1994 |
A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chelating Agents; Cisplatin; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Prognosis; Radiotherapy Dosage; Survival Rate; Thiosulfates | 1994 |
12 other study(ies) available for sodium thiosulfate and Head and Neck Neoplasms
Article | Year |
---|---|
Protective effects of sodium thiosulfate for cisplatin-mediated ototoxicity in patients with head and neck cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chelating Agents; Chemoradiotherapy; Cisplatin; Cohort Studies; Female; Head and Neck Neoplasms; Hearing Loss; Humans; Incidence; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Squamous Cell Carcinoma of Head and Neck; Thiosulfates | 2015 |
Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001.
Topics: Animals; Antineoplastic Agents; Antioxidants; Blood-Brain Barrier; Carboplatin; Cisplatin; Head and Neck Neoplasms; Hearing Loss; Humans; Methionine; Platinum Compounds; Thiosulfates | 2002 |
[Usefulness of CT-angiography for superselective intra-arterial chemotherapy for advanced head and neck cancers].
Topics: Adult; Aged; Aged, 80 and over; Angiography; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Orbital Neoplasms; Paranasal Sinus Neoplasms; Skull Base Neoplasms; Thiosulfates; Tomography, X-Ray Computed | 2002 |
Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radiotherapy Dosage; Risk Factors; Survival Analysis; Thiosulfates; Treatment Outcome | 2004 |
Sodium thiosulphate impairs the cytotoxic effects of cisplatin on FADU cells in culture.
Topics: Antineoplastic Agents; Antioxidants; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Head and Neck Neoplasms; Humans; Thiosulfates; Tumor Cells, Cultured | 2006 |
Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
Topics: Age Factors; Antidotes; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Head and Neck Neoplasms; Hearing; Hearing Loss, Sensorineural; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Radiation Dosage; Risk Factors; Thiosulfates | 2007 |
Intra-arterial chemotherapy less intensive than RADPLAT with concurrent radiotherapy for resectable advanced head and neck squamous cell carcinoma: a prospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Prospective Studies; Thiosulfates; Treatment Outcome | 2007 |
[Pharmacokinetics of cisplatin and the effect of sodium thiosulfate].
Topics: Cisplatin; Drug Administration Schedule; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Kinetics; Spectrophotometry, Atomic; Thiosulfates | 1984 |
Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.
Topics: Adult; Antidotes; Antineoplastic Agents; Audiometry, Pure-Tone; Auditory Threshold; Carcinoma, Squamous Cell; Chelating Agents; Cisplatin; Cochlea; Cohort Studies; Combined Modality Therapy; Female; Follow-Up Studies; Head and Neck Neoplasms; Hearing; Hearing Disorders; Hearing Loss, High-Frequency; Humans; Incidence; Infusions, Intra-Arterial; Male; Middle Aged; Radiotherapy Dosage; Thiosulfates; Tinnitus; Vestibular Diseases | 1997 |
The predictive value of tumor regression rates during chemoradiation therapy in patients with advanced head and neck squamous cell carcinoma.
Topics: Antidotes; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Prospective Studies; Survival Rate; Thiosulfates; Time Factors; Treatment Outcome | 1997 |
Acute and chronic changes in swallowing and quality of life following intraarterial chemoradiation for organ preservation in patients with advanced head and neck cancer.
Topics: Acute Disease; Antidotes; Antineoplastic Agents; Chronic Disease; Cisplatin; Combined Modality Therapy; Deglutition; Deglutition Disorders; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Male; Neoplasm Staging; Organ Preservation; Patient Satisfaction; Prognosis; Quality of Life; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Surveys and Questionnaires; Thiosulfates | 1998 |
[Pharmacokinetic study of cisplatin and sodium thiosulfate in two-route-infusion chemotherapy].
Topics: Cisplatin; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Kinetics; Thiosulfates | 1986 |